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Gene–environment interactionAims: Close to one third of patients with major depression show increases in pro-inflammatory cyto-
kines, which are in turn associated with risk for inflammatory disease. Genetic variants that enhance
immune reactivity may thus enhance inflammatory and depressive reactions to stress. The aim of the
present study was to investigate a trio of functional SNPs in the promoter regions of IL6 (-174G>C,
rs1800795), IL1b (-511C>T, rs16944), and TNF (-308G>A, rs1800629) as moderators of the relationship
between chronic stress exposure and elevations in depressive symptoms.
Methods: Participants were 444 Australian youth (mean age = 20.12) whose exposure to chronic stress in
the past 6 months was assessed using the semi-structured UCLA Life Stress Interview, and who com-
pleted the Beck Depression Inventory II at ages 15 and 20. Between ages 22 and 25, all participants in
the selected sample provided blood samples for genotyping.
Results: In line with a hypothesized moderation effect, -174G allele carriers at IL6 had fewer depressive
symptoms following interpersonal stress, relative to C/C homozygotes with equal interpersonal stress
exposure. However, IL6 genotype did not moderate the effects of non-interpersonal stress exposure
(i.e., financial, work and health-related difficulties) on depression. Also in line with hypotheses, the -
511C allele in IL1b, previously associated with higher IL-1b expression, was associated with more severe
depression following chronic interpersonal stress exposure, relative to T/T homozygotes. Again, the mod-
erating effect was specific to interpersonal stressors and did not generalize to non-interpersonal stress.
TNFwas not a moderator of the effects of either interpersonal or non-interpersonal stress on later depres-
sion outcomes.
Conclusion: Findings were consistent with the hypothesis that pro-inflammatory genetic variation
increases the risk of stress-induced depression. The present results provide evidence of a genetic mech-
anism contributing to individual differences in depressive symptomatology following interpersonal
stress exposure.
Published by Elsevier Inc.1. Introduction
Depression is moderately heritable and often manifests follow-
ing exposure to psychosocial stress (Kendler et al., 1995, 2001). Acti-
vation of the inflammatory response,measured by increasedplasma
levels of pro-inflammatory cytokines, including interleukin-1b (IL-
1b), interleukin-6 (IL-6), tumor-necrosis factor alpha (TNF-a), andC-reactive protein (CRP), has been shown to follow exposure to psy-
chosocial stress, and is associated with rises in depressive symp-
toms and with major depressive disorder (Dowlati et al., 2010;
Howren et al., 2009; Matthews et al., 2007, 2010; Miller and Cole,
2012; Pasco et al., 2010; Raison and Miller, 2011; Van Den
Biggelaar et al., 2007). Genetic variants that enhance immune reac-
tivity may enhance depressive reactions to stress, creating vulnera-
bility to depressive disorders. To our knowledge, the present study
is the first to examine the interaction between stress exposure and
polymorphisms of the inflammatory response as a predictor of
depressive symptoms.
Table 1
Socio-demographic and genetic characteristics of study participants.
Males (n = 170) Females (n = 250)
BDI-II age 15 (SD) 5.20 (6.76) 6.30 (7.43)
BDI-II age 20 (SD) 4.84 (6.08) 7.86 (9.71)
MDE at age 20 (yes/no) 12/158 31/219
Maternal depression history (yes/no) 76/94 111/139
IL6 -174G>C
CC 61 95
GC 85 110
GG 24 45
TNF -308G>A
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also increases pro-inflammatory cytokine production (Dickerson
et al., 2009; Monroe et al., 1999; Slavich et al., 2010a,b). Chronic
exposure to interpersonal stress is associated with persistent and
unhealthy inflammatory activity (Dhabhar, 2009, 2014; Miller
et al., 2009). For instance, older adults who endorse high levels of
loneliness show increased expression of pro-inflammatory genes
and decreased expression of anti-inflammatory factors in leuko-
cytes, compared to those who feel socially integrated (Cole et al.,
2007).
A functional SNP in IL6 (-174G>C) has received attention in the
literature for its effects on interpersonal stress-related IL6 expres-
sion (Cole et al., 2010; Schultze-Florey et al., 2012). Possession of a
G allele at -174 increases expression of IL-6 mRNA and plasma
levels of IL-6, following exposure to the stress hormone norepi-
nephrine, and also in response to grief in midlife and older adults
(Cole et al., 2010; Schultze-Florey et al., 2012).
Of developmental relevance to our study, this locus may have
opposite effects on cytokine expression in response to interper-
sonal stressors in youth. In a study of 17–19 year olds exposed to
varying levels of psychosocial stress, those with CC genotypes
had greater plasma CRP, a marker of chronic IL-6 production, com-
pared to GG or GC genotypes (Cole et al., 2011). One interpretation
of the changing allele of risk by age is that the G allele provides
protection against inflammation prior to reproductive age, but
becomes sensitized to stress during the transition to adulthood,
likely reflecting evolutionary adaptations to promote survival early
in life (Cole et al., 2010; Williams, 1957).
Although not previously investigated as moderators, TNF -
308G>A has been directly linked to depressive symptoms inwomen
with breast cancer, a context likely to include stress exposure, and
to a higher rate of attempted suicide among patients with MDD
(Bower et al., 2013; Kim et al., 2008, 2013, but see Lotrich et al.,
2010, for non-significant relationship to depression in interferon-
alpha patients), and IL1b -511C>T has been found to predict failure
to remit after antidepressant treatment (Baune et al., 2010). Stress
exposure was not measured in these investigations, and to our
knowledge no study has undertaken a gene–environment approach
to understanding the impact of these loci on risk for depression.
The primary aim of the present study was to examine IL6
(-174G>C, rs1800795; Smith and Humphries, 2009) as a moderator
of depressive reactions to chronic stress exposure in a large cohort
of adolescents, given the relevance of IL6 to stress-induced inflam-
mation and mood. We were also interested in examining IL1b
(-511C>T, rs16944, Dixon et al., 2007) and TNF (-308G>A,
rs1800629, Abraham and Kroeger, 1999; McGuire et al., 1994;
Nadel et al., 1996, but see Bayley et al., 2004) as moderators of
the stress-depression relationship, based on their association with
changes in pro-inflammatory cytokine expression, and preliminary
evidence of their relevance to mood symptoms. Given the young
age of the present sample, and the findings of Cole et al. (2010),
we hypothesized that the C allele in IL6 would confer risk for
stress-induced changes in depression. We hypothesized that the
high expression variants of IL1b and TNF would potentiate
increases in depressive symptoms following exposure to chronic
stress. We were particularly interested in whether genetic moder-
ation would be specific to chronic interpersonal stress, or would
generalize to non-interpersonal stressors as well.AA 2 8
GA 43 73
GG 125 169
IL1b -511C>T
TT 76 113
TC 72 115
CC 22 22
Asthma (yes/no) 12/155 23/2222. Method
2.1. Participants
Participants were 444 young adults, ages 22–25, drawn from
the much larger University of Queensland Study of Pregnancy(MUSP) birth cohort, based on their participation in a genetic sub-
study. The parent study enrolled 7223 publicly supported mater-
nity patients and their children born at Mater Misericordiae
Mothers’ Hospital, in Brisbane, Australia between 1981 and 1984
(Keeping et al., 1989; see Table 1). Mothers in the original MUSP
cohort completed self-report questionnaires that measured symp-
toms of depression using the Delusions-Symptoms States Inven-
tory (DSSI; Bedford et al., 1976) during pregnancy, at birth, and
at child ages 6 months and 5 years (see Najman et al., 2005, for full
details of the sample selection). When the children turned 15 years
old, a sample of 815 families was selected, oversampling for mater-
nal depression, for a substudy of outcomes in offspring of
depressed and never-depressed mothers. Further details concern-
ing the selection of this sample are provided in Hammen and
Brennan, 2001.
Participants in the selected sample were re-contacted when
youth turned 20 for additional psychological assessment, and 706
mother–child pairs completed the age 20 data collection. Between
the ages of 22 and 25, the 815 youth who participated in the age 15
assessment were invited to provide blood samples for genetic anal-
yses. Failure to respond to requests for participation, medical prob-
lems, death and invalid DNA samples resulted in a total of 444
participants who contributed blood samples for the genetic data
collection, and the current study sample is limited to these individ-
uals, focusing on psychosocial measures taken at ages 15 and 20,
supplemented by health survey data collected in early life that
assessed the presence or absence of asthma. This final sample
was evenly split by gender (49.4% female), predominantly Cauca-
sian (92.1%), and came from lower and lower-middle income
homes. Non-Caucasian participants were Asian (4.1%), Maori/Paci-
fic Islander (1.1%), Australian Aborigine (2%) and other (0.2%).
Those who completed the genetic study were more likely to be
female (v2(1) = 33.66, p < .001), but were no more likely to have
mothers with a history of depression (v2(1) = .013, n.s.) compared
to youth that did not complete the genetic study. There were no
differences in ethnicity (v2(5) = 6.40, n.s.), depressive symptoms
at ages 15 or 20 (t(631) = 1.44, n.s.; t(803) = .83, n.s.), or in
chronic stress exposure in the 6 months prior to age 20 (interper-
sonal: t(813) = 1.97, n.s.; non-interpersonal: t(813) = 1.26, n.s.),
between the overall sample and the genetic subsample.
2.2. Procedure
Mothers and children in the sample completed the Structured
Clinical Interview for DSM-IV (SCID) and self-report measures of
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spring turned 15, and again when they turned 20. Information
was gathered in the family home or a location convenient for the
participants and interviewer. Postgraduate psychology students
were trained to appropriately conduct and reliably score these
interviews. Participants all gave informed consent, or assent in
the case of minors. The institutional review or ethics panels of
the University of Queensland, University of California, Los Angeles,
and Emory University approved the research protocol.
Youth were contacted in 2006, between ages 22 and 25, regard-
ing participation in a blood draw for genotyping purposes. Those
who wished to participate in the genotyping study were mailed
consent forms, a blood collection kit, and questionnaires. They
were instructed to have a blood draw completed by a local phle-
botomist, and the samples were then picked up by courier and
transported to the Genetic Epidemiological Laboratory of the
Queensland Institute of Medical Research (QIMR). DNA extraction
from leukocytes took place via the salting out method (Miller
et al., 1988). The resultant ‘‘stock’’ DNA was eluted in 400 ll of
1 Tris–EDTA buffer (10 mM Tris pH 8.0, 1 mM EDTA pH 8.0)
and ranged in concentration from 100 ng/ll to 100 lg/ll. DNA
samples were stored at the QIMR laboratory until 2011, when ali-
quots of DNA were sent to the UCLA Social Genomics Core Labora-
tory for genotyping. Allelic variation at IL6 (G>C; rs1800795), IL1b
(-511 C>T; rs16944) and TNF (-308 G>A; rs1800629) was assayed
by a commercial TaqMan Genotyping Assay (Applied Biosystems,
Foster City, CA) performed on an iCycler real-time PCR instrument
(BioRad, Hercules, CA) following the manufacturer’s specified pro-
tocol (Cole et al., 2010).
Test–retest reliability of duplicated specimens yielded a total
genotyping error rate below 1%. All three polymorphisms were in
Hardy–Weinberg equilibrium (v2(1,444) values: IL1b -511 = 0.26,
IL6 -174 = 0.13, TNF -308 = 0.08, all p-values > .05). Population level
minor allele frequencies of the three SNPs were 18.5% at IL6, 46.5%
at IL1b, and 9.6% at TNF, indicating that allelic variation at these loci
is common, and could reasonably account for differences in
depressive symptoms.
2.3. Measures
2.3.1. Depression symptoms
Youth self-report of depressive symptoms was collected at ages
15 and 20 using the Beck Depression Inventory-II (BDI-II; Beck
et al., 1996), a continuous measure that has shown excellent inter-
nal consistency, and has been validated against clinical ratings of
depression (Beck et al., 1988). Internal consistency was very good
in the present sample (Crohnbach’s a = .90). Scores on the BDI-II
at age 15 ranged from 0 to 32 (M = 6.20, SD = 6.19). At age 20,
scores ranged from 0 to 52 (M = 7.44, SD = 8.40; see Table 1). Use
of a continuous measure of depressive symptoms provides a sensi-
tive test of the present study’s gene–environment interaction
hypotheses, while the use of diagnostic categories of depressive
disorders would greatly reduce the ability to detect effects. Further,
diagnostic categories of depressive disorders have shown only
slight advantage over subsyndromal depressive symptoms as indi-
cators of functional impairment (Judd et al., 1996).
2.3.2. Chronic interpersonal stress
Youth were interviewed at age 20 using the semi-structured
UCLA Life Stress Interview (LSI; Hammen and Brennan, 2001),
which was developed to assess chronic, ongoing stressful condi-
tions in major life domains, as well as acutely stressful life events,
and has been validated for use in young adult samples (Adrian and
Hammen, 1993; Rao et al., 1999). Using a set of standardized ques-
tions and follow up prompts, interviewers asked participants to
describe their functioning in eight different life domains, half ofthem related to social functioning, over the past 6 months. Func-
tioning in each domain was then scored on a scale of 1–5, with
half-points permitted, where 1 indicates superior functioning and
5 indicates significantly impaired functioning. For example, in
the romantic relationship domain, a score of 1 would be given to
an individual who has a stable romantic relationship that is low
in conflict and high in self-disclosure, and who engages in frequent
positive interactions with their partner. An individual who reports
a close relationship that is lacking in disclosure, or who experi-
ences regular conflict in their relationship would score a 3. An indi-
vidual who reports isolation from their partner or severe or
frequent conflict with their partner would receive a score of 5.
The four domains with social content (romantic relationships, rela-
tionship with a best friend, family relationships, and social life)
were then summed to create a composite score reflecting chronic
interpersonal stress, where higher scores indicate greater distress.
The remaining four domains (work, finances, personal health, fam-
ily health) were summed to create a composite measure of non-
interpersonal chronic stress. Composite scores across interpersonal
domains ranged from 4 to 18.5 with a mean of 10.04 (SD = 2.59).
Composite scores across non-interpersonal domains ranged from
3 to 15 with a mean of 7.59 and a standard deviation of 2.02.
2.3.3. Maternal depression
Mothers were interviewed when their child turned 15, using
the Structured Clinical Interview for DSM-IV (SCID-IV; First et al.,
2012). Nearly half (43.5%) of the mothers in this high-risk sample
met criteria for a current or past episode of major depression or
dysthymic disorder by youth age 15.
2.4. Statistical analysis
All statistical tests were two-sided and conducted using SPSS
statistical package, version 18.0 for Macintosh. The simple effects
of significant interactions were examined in Stata 12.0 for Macin-
tosh. All stress variables were mean-centered to reduce multicol-
linearity, and missing data (3 cases at age 15, and 6 cases at 20)
were replaced with the variable mean. Maternal depression was
entered as a covariate in all analyses, as depression in the mother
has been linked to increased exposure to psychosocial stress, and
also contributes heritable risk for depression. Additionally, gender
and scores on the BDI-II at age 15 were entered as covariates to
insure that earlier depressive symptoms, especially among women,
did not better account for current symptoms. Childhood asthma
was the most common inflammatory illness based on health diag-
noses recorded at age 5, and was entered as a covariate to control
for possible confounding effects of heightened inflammation on
depression.
Linear regression was used to test stress exposure in the past
6 months, inflammatory genotypes, and the interactions of stress
and genotype, as predictors of depressive symptoms at age 20.
All genotypes were coded as three-level variables (0 = minor allele
homozygotes, 1 = heterozygotes, 2 = major allele homozygotes).
Post-hoc contrasts were planned to evaluate the simple effects of
significant interactions between genotype and stress. At IL1b and
TNF, contrasts evaluated the hypothesis that dominant homozy-
gotes would have greater levels of depression compared to hetero-
zygotes and to recessive homozygotes. In adolescents, the allele of
risk at IL6 has been identified as -174C, and post-hoc contrasts
compared CC homozygotes to CG and GG genotypes. In light of
the conflicting findings regarding the allele of risk at IL6, we also
compared CG and GG genotypes. Given the a priori hypotheses
and exploratory nature of the analyses, correction for multiple
testing was not planned. Following the primary analyses, the mod-
els were re-run restricting the sample to Caucasians, the largest
ethnic group, to examine the impact of ethnicity on genetic effects.
1 Based on the results obtained with the individual genotypes, an exploratory
analysis of additive risk at IL6 and IL1b (-174C in IL6 and -155T in IL1b) was
conducted. A risk index was created with a range of 0–4 risk alleles, and tested as a
moderator of chronic interpersonal stress at age 20, predicting BDI-II score
controlling for maternal depression, asthma, gender and age 15 BDI-II. The interaction
of the genetic index and stress was significant (b = 0.45, SE = 0.14, p = .001), with each
additional risk allele predicting greater mean depressive symptoms, except for
participants who had zero risk alleles. Participants with zero risk alleles had the
second lowest mean depression scores, between participants with one and partic-
ipants with two risk alleles. When repeated in the sample’s largest ethnic group
(Caucasians), the interaction term held (b = .51, SE = .14, p < .001). Although this
analysis had increased power to detect effects, it was not based on our origina
hypotheses, and for this reason, we do not include it as a primary analysis.
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We first tested the specificity of chronic interpersonal stress as
a predictor of depressive symptoms. Both interpersonal and non-
interpersonal stress remained significant when entered in a single
model predicting age 20 BDI-II score (b = 0.92, SE = 0.17, p < .001
for interpersonal stress; b = 0.91, SE = 0.21, p < .001 for non-inter-
personal stress).
In line with previous work in young, physically healthy samples
(Misener et al., 2008), the individual genetic polymorphisms did
not predict depressive symptoms at age 20 (all p values > .10).
Inflammatory genotypes were then examined as predictors of the
magnitude of chronic stress exposure. IL1b genotype was found
to predict chronic non-interpersonal stress exposure (b = .36,
SE = .14, p = .01), such that exposure increased with the number
of minor alleles. There were no significant associations of IL6 or
TNF with either interpersonal or non-interpersonal stress exposure
(p values between .54 and .89).
3.1. Moderation of the depression and stress exposure relationship by
genotype
In all models, maternal depression, age 15 BDI-II score, and
exposure to chronic interpersonal stress remained significant as
predictors of age 20 depressive symptoms following the addition
of the main and interactive effects of genotype and stress (all
p’s < .01, see Table 2 for interpersonal stress results).
3.1.1. Moderation by IL6 genotype
Linear regression was used to determine whether allelic varia-
tion at IL6 might moderate the impact of stress exposure on age
20 depression severity, over and above the effects of the covariates.
An interaction of IL6 genotype and chronic interpersonal stress
exposure was detected and deconstructed into its simple effects
(b = .44 [95% CI: .803 to .078], D R2 = 0.01, D F = 5.71,
p = .017, see Table 2). Post-hoc contrasts revealed significantly
higher depressive symptoms in CC homozygotes compared with
GG homozygotes (b = 0.98, SE = 0.42, p = 0.02), and marginally
higher depressive symptoms in CC homozygotes compared with
heterozygotes, given equal exposure to chronic interpersonal
stress (b = 0.58, SE = 0.31, p = 0.07; see Fig. 1). The contrast
between GG and GC genotypes was not significant (b = 0.40,
SE = 0.41, p = 0.34).
IL6 genotype did not moderate the effects of chronic non-inter-
personal stress on depressive symptoms at age 20 (b = .36 [95%
CI: 0.82 to 0.10], D R2 = 0.004, D F = 2.40, p = .12).
3.1.2. Moderation by IL1b and TNF genotypes
The interaction of IL1b genotype and chronic interpersonal
stress exposure predicted later depressive symptoms, even
accounting for the effects of the covariates (b = 0.44, [95% CI:
0.06 to 0.82], D R2 = .009, D F = 5.29, p = .022, see Table 2 and
Fig. 2). Contrasts between genotypes at IL1b revealed marginally
significant simple effects, such that CC homozygotes developed
more depressive symptoms relative to TT homozygotes (b = 0.88,
SE = 0.45, p = .05), and relative to heterozygotes (b = 0.59,
SE = 0.31, p = .06).
Allelic variation at IL1b was not a significant moderator of the
effects of non-interpersonal stress exposure on depressive symp-
toms (b = .43, SE = .26, p = .10).
Variation at TNF was not associated with differences in depres-
sive symptoms as a function of chronic interpersonal stress
(b = .41, SE = 0.26, p = .11, see Table 2), but had a marginally
significant effect on depressive symptoms in response to non-inter-
personal stress (b = 0.60 [95% CI: 1.27 to 0.06], D R2 = 0.005, DF = 3.18, p = .08). The simple effects of the TNF  non-interpersonal
stress interaction were not significant (AA vs. GA: b = 0.69,
SE = 2.01, p = 0.73; AA vs GG: b = 1.12, SE = 2.00, p = 0.57)1
Following the primary analyses, we reran the models restricting
the sample to Caucasians, the predominant ethnicity. The interac-
tion effect of chronic interpersonal stress and IL6 genotype on
depression severity held under these conditions: b = .48 [95%
CI: 0.86 to 0.11], D R2 = 0.01, D F = 6.36, p = .01. Consistent with
the results in the full sample, IL6 genotype was not a moderator of
the relationship between chronic non-interpersonal stress and
depression (b = .39, [95% CI: 0.87 to 0.08], D R2 = 0.01, D
F = 2.63, p = .11). The interaction of chronic interpersonal stress
and IL1b continued to predict depressive symptomatology:
b = 0.49, [95% CI: 0.10 to 0.88], D R2 = .01, D F = 6.01, p = .02. When
restricted to Caucasians, IL1b remained non-significant as a moder-
ator of non-interpersonal stress, although the p-value was reduced
to 0.08: b = 0.49, [95% CI: 0.05 to 1.03], D R2 = .01, D F = 3.17,
p = .08. The interaction effects of TNF and chronic stress remained
non-significant (TNF  interpersonal stress: b = .45, SE = 0.27,
p = .10, TNF  non-interpersonal stress: b = 0.58, SE = 0.35,
p = .10). Analyses were repeated using similar stress and depres-
sion variables at the age 15 measurement time point, when the
range in BDI-II symptoms (0–32) reflected lower severity of
depression, compared with 0–52 at age 20, and no pattern of
gene–environment interaction was identified [details available on
request].4. Discussion
The aim of the present study was to evaluate the interaction of
chronic stress with three pro-inflammatory polymorphisms as pre-
cipitants of depressive symptoms in young adulthood. We hypoth-
esized that variation at IL6, IL1b and TNF would potentiate the
effects of interpersonal stress on the development of depressive
symptoms. As hypothesized, interactive effects were revealed at
loci in IL6 and IL1b that accounted for differences in depressive
symptoms, over and above the contributions of maternal depres-
sion history, earlier depressive symptoms, gender, and asthma
diagnosis. These interactive effects were specific to interpersonal
stress, as findings for non-interpersonal stress exposure were not
significant. Findings were also specific to the age 20 time point.
Of note, the range of BDI-II scores at age 15 (0–32) indicated lower
severity of depression compared to age 20, when scores ranged
from 0 to 52. A possibility is that the identified genetic effects
emerge in late adolescence, which is in line with the antagonistic
pleiotropy hypothesis generated by Cole et al. (2011) for the effects
of IL6. Previous longitudinal work with twins has also found
changes in genetic and environmental influences on depression
with age (Lau and Eley, 2006; Kendler et al., 2008).
There were no main effects of genotype on depressive symp-
toms. Interestingly, the present study also found evidence of a
gene–environment correlation at IL1b, so that exposure to non-
interpersonal stress increased with each -511C allele. Further,
l
Table 2
Hierarchical linear regression analyses of inflammatory genotypes, chronic interpersonal stress severity in the past 6 months, and their interactions, predicting depressive
symptoms at age 20.
Predictor Age 20 BDI-II score
b SE b F change for interaction term
IL6 model
Maternal depression 2.01 0.65 3.09**
Gender 0.51 0.65 0.78
Asthma 0.14 0.88 0.01
Age 15 BDI-II score 0.41 0.05 0.32***
Chronic interpersonal stress age 20 1.39 0.19 0.43***
IL6a 0.17 0.45 0.02
Chronic interpersonal stress age 20  IL6 0.44 0.18 0.14* 5.71*
IL1b model
Maternal depression 1.96 0.65 0.12**
Gender 0.53 0.65 0.03
Asthma 0.00 0.89 0.00
Age 15 BDI-II score 0.41 0.05 0.32***
Chronic interpersonal stress age 20 0.76 0.19 0.24***
IL1ba 0.38 0.49 0.03
Chronic interpersonal stress age 20  IL1b 0.44 0.22 0.13* 5.29*
TNF model
Maternal depression 2.07 0.65 0.13**
Gender 0.46 0.65 0.03
Asthma 0.21 0.88 0.01
Age 15 BDI-II score 0.41 0.05 0.32***
Chronic interpersonal stress age 20 1.74 0.46 0.54***
TNFa 0.56 0.60 0.04
Chronic interpersonal stress age 20  TNF 0.41 0.26 0.22 2.53
* p < .05.
** p < .01.
*** p < .001.
a Coded as 0/1/2 major alleles.
Fig. 1. Allelic variation at -174G>C in IL6 moderated the relationship between
chronic interpersonal stress in the 6 months prior to age 20 and depressive
symptoms at age 20 (b = .14, p = .02). The slope of the regression line for CC
homozygotes (solid line) was significantly different from the slope of the regression
line for GG homozygotes (dotted line) (b = 0.98, SE = 0.42, p = 0.02). There was a
marginally significant contrast in the slopes of the regression lines for CC
homozygotes compared to heterozygotes (dashed line) (b = 0.58, SE = 0.31,
p = 0.07). At the same levels of chronic interpersonal stress, CC homozygotes
showed higher depressive symptoms compared to GG homozygotes.
Fig. 2. Allelic variation at -511 C>T in IL1b moderated the relationship between
chronic interpersonal stress in the 6 months prior to age 20 and depressive
symptoms at age 20 (b = 0.13, p = .022). The slope of the regression line for TT
homozygotes (solid line) was marginally different from the slope of the regression
line for CC homozygotes (dotted line) (b = 0.88, SE = 0.45, p = .053). There was also a
marginally significant contrast in the slopes of the regression lines for TT
homozygotes and heterozygotes (dashed line) (b = 0.59, SE = 0.31, p = .060).
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awaits future replication.
The pattern of results for IL1b is consistent with previous work
that identified the high expression -511C allele as a risk for poor
response to pharmacotherapies for depression, and for early onset
of depression and higher depressive symptom severity (Dixon
et al., 2007; Hwang et al., 2009; Tadic et al., 2008; Yu et al.,
2003). No previous empirical work has examined a gene–environ-
ment interaction at this locus, but the finding is in line with the
pathogen host defense theory (PATHOS-D), which posits that
pro-inflammatory genotypes enhance depression risk (Raison and
Miller, 2012).
Results of analyses at IL6 revealed that participants homozy-
gous for -174C developed higher levels of depressive symptoms
following exposure to chronic interpersonal stress when compared
to those with one or more -174G alleles. This finding is consistent
with a previous investigation that found elevations in plasma CRP
following stress exposure in adolescents homozygous for -174C
compared with -174G carriers (Cole et al., 2011). In contrast, -
174G is associated with increased IL-6 expression following stress
exposure in older adults (Cole et al., 2010; Schultze-Florey et al.,
2012). To explain these conflicting results, Cole et al. (2011)
hypothesize that -174G has undergone selection for its protection
against stress-induced inflammation in adolescence, and becomes
sensitized to stress after child-bearing age is reached. This is con-
sistent with age-dependent antagonistic pleiotropy, as any detri-
mental effects of -174G on survival after reproductive age would
not affect its retention in the population (Williams, 1957). No
study has directly evaluated the hypothesis that aging leads to a
change in the allele of risk at IL6, despite opposing findings in older
adults and adolescents. Replication of the present results is needed,
and further study should include measures of stress exposure,
inflammatory markers and depressive outcomes in a single
investigation.
Taken together, the present results suggest that possession of
high expression alleles at IL6 and IL1b increase depression risk fol-
lowing interpersonal stress exposure in the present sample. Fur-
ther, these effects were specific to interpersonal stress and did
not generalize across other types of adverse experience, potentially
suggesting a specific biological vulnerability to interpersonal
stress. Nesse (2009) has hypothesized that in our ancestry, inter-
personal stress may have acted as a warning signal for physical
confrontation or social abandonment. Individuals who were able
to mount an early immune response to distressing social situations
would have had an advantage in healing infections and wounds
resulting from physical conflict or attack, after the loss of commu-
nity protection. In support of this theory, the biological changes
induced by interpersonal stress mitigate injury and infection
(Cole et al., 2007, 2011; Dhabhar, 2009). Although brief activation
of the inflammatory response promotes healing, chronic activation
leads to dysregulation of immunological processes and elicits
depressive symptoms (Dhabhar, 2014; Dowlati et al., 2010;
Howren et al., 2009; Raison and Miller, 2011). Theoretically then,
individuals genetically predisposed to inflammation would be at
increased risk for developing depressive illness when exposed to
chronic interpersonal stress.
The present study was not designed to assess possible mecha-
nisms linking stress exposure and inflammatory genotypes with
depression. It may be that risk genotypes increase the production
of pro-inflammatory cytokines in response to stress, which
increases the risk of depression onset via action on neurotransmit-
ter systems involved in depression (Dantzer et al., 2011; Myint
et al., 2007). Consistent with this theory, findings from longitudinal
studies in older populations indicate that rises in inflammation
precipitate later depression (Matthews et al., 2007, 2010; Pasco
et al., 2010; Van Den Biggelaar et al., 2007). In never depressedyouth, however, inflammatory levels were normative before
depression onset, and a first depressive episode was found to
increase inflammatory factors. Copeland et al. (2012) found that
increases in pro-inflammatory cytokines arise as a consequence
of depression onset in youth. Miller and Cole (2012) found that
in young women, the first onset of a major depressive episode
was accompanied by increases in plasma CRP and IL-6 that were
more pronounced in women with higher levels of childhood stress.
In women with a history of early stress, heightened inflammation
persisted beyond the resolution of the MDE and predicted a second
depressive episode. The role of age in determining the complex
relationship between inflammation and depression is an important
question for future research. In addition, future studies should
explore the role of psychological resiliency and risk factors, includ-
ing cognitive appraisal of stressful events and coping skills that
may affect inflammatory changes and depression risk following
stress exposure.
The present study had a number of strengths, including hypoth-
eses based in theory, longitudinal assessment of the relationship
between stress and depression, and validated, independently-rated
measurement of chronic interpersonal and non-interpersonal
stress using the semi-structured UCLA Life Stress Interview, which
reduced the sample size needed to detect a significant interactive
effect, and increased the validity of the findings (Caspi et al.,
2010). Several alternative explanations for the present depression
outcomes were ruled out, including effects of maternal depression,
a factor that influences genetic makeup and psychosocial stress
exposure, as well as prior elevations in depressive symptoms,
gender, and inflammatory illness (asthma).
Limitations of the present study include the retrospective
assessment of chronic stress, and narrow age range of participants,
which prevents a direct evaluation of the hypothesis that the allele
of risk at IL6 differs by age. The sample size was relatively small for
a candidate gene study, which reduced our statistical power. The
present study is an analysis of gene–environment interaction with
specific a priori hypotheses dictated by theory, and we present the
findings without correction for multiple analyses. Because of the
limited sample size and restricted power, we present the analyses
as an extension of previous work that identifies these SNPs as
depression or stress-relevant. We readily acknowledge that the
present results are not a conclusive description of the effects of
the identified SNPs on the stress-depression relationship, as epista-
sis and other effects could also be relevant. Therefore, replication in
a larger sample is necessary before any firm conclusions can be
drawn from the present analyses.
When analyses were repeated within the largest ethnic group
(Caucasians), the primary results held. Of interest, the interaction
of IL1b with non-interpersonal stress remained non-significant,
although a slightly larger difference between depression symptom
means of allele groups (p reduced from .10 to .08) suggested that
sample size may play a role in the magnitude of effects for different
ethnicities. In fact, each of the gene  chronic stress effects moved
closer to significance (p-values between .01 and .11) following the
restriction to Caucasians, indicating that moderation by each geno-
type examined in the present study may be worth investigating
further in larger samples. The small number of non-Caucasian sub-
jects prevented an ethnically stratified analysis. Even considering
these limitations, the present data are novel in finding that inflam-
matory genotypes moderate the effect of chronic interpersonal
stress on depressive symptoms.
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